Citation: | LIANG Feng, LI Duo, WANG Rongbin, SHU Chang, DING Li. Pharmacokinetics and absolute bioavailability of isoschaftoside in rat by LC-MS/MS[J]. Journal of China Pharmaceutical University, 2019, 50(1): 75-80. DOI: 10.11665/j.issn.1000-5048.20190110 |
[1] |
Zhang LL,Xu W,Xu YL,et al.Therapeutic potential of Rhizoma Alismatis:a review on ethnomedicinal application,phytochemistry,pharmacology,and toxicology[J].Ann NY Acad Sci,2017,1401(1):90-101.
|
[2] |
Gao X, Sun C, Yu Z, et al. Correlation analysis between the chemical contents and bioactivity for the quality control of Alismatis Rhizoma[J].Acta Pharm Sin B,2018,8(2):242-251.
|
[3] |
Chu Y,Jiang H,Ju J,et al.A metabolomic study using HPLC-TOF/MS coupled with ingenuity pathway analysis:intervention effects of Rhizoma Alismatis on spontaneous hypertensive rats[J].J Pharm Biomed Anal,2016,117:446-452
|
[4] |
Shan DS,Ming ZH,Chun Qi B,et al.Nematocidal flavone-C-glycosides against the root-knot nematode(Meloidogyne incognita)from Arisaema erubescens tubers[J].Molecules,2011,16(6):5079-5086.
|
[5] |
Dai Y,Tan A,Chen H,et al.Quantification of desoxyrhapontigenin(4-methoxyresveratrol)in rat plasma by LC-MS/MS:application to pre-clinical pharmacokinetic study[J].J Pharm Biomed Anal,2018,153:95-101.
|
[6] |
Yang M,Dong Z,Jiang X,et al.Determination of S-allylmercaptocysteine in rat plasma by LC-MS/MS and its application to a pharmacokinetics study[J].J Chromatogr Sci,2018.doi: 10.1093/chromsci/bmy001.
|
[7] |
Chen JT, Guo XM, Yang P, et al. Quantitative analysis of the cyclic peptide GG-8-6 in rat plasma using LC-MS/MS and its application to a pharmacokinetic study[J].J Pharm Biomed Anal,2018,159:217-223.
|
[8] |
Cai J,Zhu L,Xu Y,et al.A UPLC-MS/MS method for determination of schaftoside in rat plasma and its application to phamacokinetic study[J].Lat Am J Pharm,2016,35(3):545-550.
|
[1] | LIU Li, PEI Siran, WU Huali, ZHAO Qingshun, PENG Jixian, SHANG Jing. Drug screening model of treating pigmentation disorders in tyrp1a transgenic zebrafish[J]. Journal of China Pharmaceutical University, 2016, 47(6): 740-743. DOI: 10.11665/j.issn.1000-5048.20160618 |
[2] | SHAO Xin, YI Qianying, YANG Chunlei. Discovery of novel EphB4 inhibitors based on pharmacophore modeling and virtual screening techniques[J]. Journal of China Pharmaceutical University, 2016, 47(1): 38-47. DOI: 10.11665/j.issn.1000-5048.20160105 |
[3] | HE Hua, ZHANG Xue, WANG Yuhao, LIU Xiaoquan. Advances in pharmacokinetic and pharmacodynamic modeling of monoclonal antibody[J]. Journal of China Pharmaceutical University, 2015, 46(3): 279-288. DOI: 10.11665/j.issn.1000-5048.20150304 |
[4] | TANG Chunlei, HUANG Wenlong, QIAN Hai. Construction and application of 3D-pharmacophore model of glucokinase agonists[J]. Journal of China Pharmaceutical University, 2015, 46(2): 181-187. DOI: 10.11665/j.issn.1000-5048.20150208 |
[5] | HE Xiaobei, LIU Xiaodong. Physiologically based pharmacokinetic model of mechanism-based inhibition of theophylline/caffeine by enoxacin/ciprofloxacin[J]. Journal of China Pharmaceutical University, 2013, 44(1): 77-84. DOI: 10.11665/j.issn.1000-5048.20130113 |
[6] | REN Xin-yi, CHEN Yuan-cheng, WANG Yan, XIAO Yuan-yuan, LIU Xiao-quan. Pharmacokinetic-pharmacodynamic(PK-PD) modeling of salvianolic acid A on the plasma homocysteine in rats[J]. Journal of China Pharmaceutical University, 2012, 43(3): 260-265. |
[7] | Linear Model for Prediction of Drug Shelf Life[J]. Journal of China Pharmaceutical University, 1999, (2): 69-72. |
[8] | Yang Jinghua, Song Xiangzheng. The Markovian Model C in Pharmacokinetics[J]. Journal of China Pharmaceutical University, 1997, (1): 59-62. |
[9] | Animal ECG Automatic Sample and Analysis-process by Computer[J]. Journal of China Pharmaceutical University, 1995, (5): 304-307. |
[10] | Computer Program for the Effect Parameters of Combined Pharmacokinetic and Pharmacodynamic Model[J]. Journal of China Pharmaceutical University, 1990, (3): 142-146. |